Eric E. Morgan

968 total citations
31 papers, 797 citations indexed

About

Eric E. Morgan is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Physiology. According to data from OpenAlex, Eric E. Morgan has authored 31 papers receiving a total of 797 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 14 papers in Cardiology and Cardiovascular Medicine and 13 papers in Physiology. Recurrent topics in Eric E. Morgan's work include Ion Transport and Channel Regulation (7 papers), Cardiovascular Function and Risk Factors (7 papers) and Adipose Tissue and Metabolism (7 papers). Eric E. Morgan is often cited by papers focused on Ion Transport and Channel Regulation (7 papers), Cardiovascular Function and Risk Factors (7 papers) and Adipose Tissue and Metabolism (7 papers). Eric E. Morgan collaborates with scholars based in United States, Czechia and China. Eric E. Morgan's co-authors include Tracy A McElfresh, Margaret P. Chandler, William C. Stanley, Theodore A. Kung, Brian D. Hoit, Bina Joe, Martin E. Young, Andrea L. Nestor‐Kalinoski, Kathirvel Gopalakrishnan and Sivarajan Kumarasamy and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Communications and The FASEB Journal.

In The Last Decade

Eric E. Morgan

30 papers receiving 782 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Eric E. Morgan United States 17 359 339 189 99 83 31 797
Juan A. Rodríguez-Feo Spain 16 227 0.6× 282 0.8× 340 1.8× 88 0.9× 37 0.4× 24 829
Rob H. P. Hilgers United States 19 405 1.1× 304 0.9× 333 1.8× 127 1.3× 43 0.5× 33 1.1k
Rolf Schreckenberg Germany 20 375 1.0× 358 1.1× 168 0.9× 51 0.5× 25 0.3× 58 847
Masayuki Shimano Japan 23 395 1.1× 876 2.6× 313 1.7× 97 1.0× 31 0.4× 38 1.5k
Takafumi Iesaki Japan 17 198 0.6× 158 0.5× 261 1.4× 87 0.9× 33 0.4× 31 642
Delyth Graham United Kingdom 18 232 0.6× 293 0.9× 153 0.8× 224 2.3× 51 0.6× 32 839
Robrecht Thoonen United States 15 312 0.9× 191 0.6× 280 1.5× 30 0.3× 42 0.5× 29 719
Siva S. V. P. Sakamuri United States 18 356 1.0× 250 0.7× 163 0.9× 99 1.0× 49 0.6× 36 872
Yumiko Hiura Japan 12 579 1.6× 153 0.5× 143 0.8× 241 2.4× 128 1.5× 16 1.3k
Hongyan Dai China 20 451 1.3× 293 0.9× 105 0.6× 74 0.7× 26 0.3× 53 1.1k

Countries citing papers authored by Eric E. Morgan

Since Specialization
Citations

This map shows the geographic impact of Eric E. Morgan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eric E. Morgan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eric E. Morgan more than expected).

Fields of papers citing papers by Eric E. Morgan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eric E. Morgan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eric E. Morgan. The network helps show where Eric E. Morgan may publish in the future.

Co-authorship network of co-authors of Eric E. Morgan

This figure shows the co-authorship network connecting the top 25 collaborators of Eric E. Morgan. A scholar is included among the top collaborators of Eric E. Morgan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eric E. Morgan. Eric E. Morgan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Morgan, Patricia, et al.. (2023). Brand ferumoxytol vs. generic ferumoxytol comparison across two dosing regimens: a cardiac MRI image quality study. Pediatric Radiology. 53(13). 2622–2632. 2 indexed citations
2.
Dube, Prabhatchandra, Apurva Lad, Joshua D. Breidenbach, et al.. (2022). Cardioprotective Role for Paraoxonase-1 in Chronic Kidney Disease. Biomedicines. 10(9). 2301–2301. 7 indexed citations
3.
Morgan, Eric E., et al.. (2021). RNO3 QTL regulates vascular structure and arterial stiffness in the spontaneously hypertensive rat. Physiological Genomics. 53(12). 534–545. 2 indexed citations
4.
Zhang, Youjie, Eric E. Morgan, Xi Cheng, et al.. (2020). Intrinsic Exercise Capacity and Mitochondrial DNA Lead to Opposing Vascular-Associated Risks. Function. 2(1). zqaa029–zqaa029. 3 indexed citations
5.
Russo, Lucia, Harrison T. Muturi, Hilda E. Ghadieh, et al.. (2018). Liver-specific rescuing of CEACAM1 reverses endothelial and cardiovascular abnormalities in male mice with null deletion of Ceacam1 gene. Molecular Metabolism. 9. 98–113. 14 indexed citations
6.
Duan, Qiming, et al.. (2017). Preconditioning and Postconditioning by Cardiac Glycosides in the Mouse Heart. Journal of Cardiovascular Pharmacology. 71(2). 95–103. 16 indexed citations
7.
Cheng, Xi, Harshal Waghulde, Blair Mell, et al.. (2017). Positional cloning of quantitative trait nucleotides for blood pressure and cardiac QT-interval by targeted CRISPR/Cas9 editing of a novel long non-coding RNA. PLoS Genetics. 13(8). e1006961–e1006961. 27 indexed citations
8.
Kumarasamy, Sivarajan, Harshal Waghulde, Kathirvel Gopalakrishnan, et al.. (2015). Mutation within the hinge region of the transcription factor Nr2f2 attenuates salt-sensitive hypertension. Nature Communications. 6(1). 6252–6252. 18 indexed citations
9.
Bai, Yan, Eric E. Morgan, David R. Giovannucci, et al.. (2012). Different roles of the cardiac Na+/Ca2+-exchanger in ouabain-induced inotropy, cell signaling, and hypertrophy. American Journal of Physiology-Heart and Circulatory Physiology. 304(3). H427–H435. 33 indexed citations
10.
Kumarasamy, Sivarajan, et al.. (2011). Refined mapping of blood pressure quantitative trait loci using congenic strains developed from two genetically hypertensive rat models. Hypertension Research. 34(12). 1263–1270. 20 indexed citations
11.
Morgan, Eric E., et al.. (2010). Preconditioning by Subinotropic Doses of Ouabain in the Langendorff perfused Rabbit Heart. Journal of Cardiovascular Pharmacology. 55(3). 234–239. 22 indexed citations
12.
Kennedy, David J., Amjad Shidyak, Anna P. Shapiro, et al.. (2007). Partial nephrectomy as a model for uremic cardiomyopathy in the mouse. American Journal of Physiology-Renal Physiology. 294(2). F450–F454. 91 indexed citations
13.
Chandler, Margaret P., Eric E. Morgan, Tracy A McElfresh, et al.. (2007). Heart failure progression is accelerated following myocardial infarction in type 2 diabetic rats. American Journal of Physiology-Heart and Circulatory Physiology. 293(3). H1609–H1616. 29 indexed citations
14.
Morgan, Eric E., Margaret P. Chandler, Martin E. Young, et al.. (2006). Dissociation Between Gene and Protein Expression of Metabolic Enzymes in a Rodent Model of Heart Failure. European Journal of Heart Failure. 8(7). 687–693. 33 indexed citations
15.
Morgan, Eric E., Martin E. Young, Tracy A McElfresh, et al.. (2006). Chronic treatment with trimetazidine reduces the upregulation of atrial natriuretic peptide in heart failure. Fundamental and Clinical Pharmacology. 20(5). 503–505. 8 indexed citations
16.
Morgan, Eric E., Julie H. Rennison, Martin E. Young, et al.. (2005). Effects of chronic activation of peroxisome proliferator-activated receptor-α or high-fat feeding in a rat infarct model of heart failure. American Journal of Physiology-Heart and Circulatory Physiology. 290(5). H1899–H1904. 75 indexed citations
17.
Stanley, William C., Eric E. Morgan, Hazel Huang, et al.. (2005). Malonyl-CoA decarboxylase inhibition suppresses fatty acid oxidation and reduces lactate production during demand-induced ischemia. American Journal of Physiology-Heart and Circulatory Physiology. 289(6). H2304–H2309. 67 indexed citations
18.
Morgan, Eric E., Michael Faulx, Tracy A McElfresh, et al.. (2004). Validation of echocardiographic methods for assessing left ventricular dysfunction in rats with myocardial infarction. American Journal of Physiology-Heart and Circulatory Physiology. 287(5). H2049–H2053. 109 indexed citations
19.
Jansson, Svante & Eric E. Morgan. (2004). Biochemical Effects from Treatment with Bisphosphonate and Surgery in Patients with Primary Hyperparathyroidism. World Journal of Surgery. 28(12). 1293–1297. 5 indexed citations
20.
Morgan, Eric E., et al.. (2002). Prolonged isoproterenol infusion impairs the ability of β2-agonists to increase alveolar liquid clearance. American Journal of Physiology-Lung Cellular and Molecular Physiology. 282(4). L666–L674. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026